{"id":53230,"date":"2023-01-24T15:02:52","date_gmt":"2023-01-24T14:02:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/"},"modified":"2023-01-24T15:02:52","modified_gmt":"2023-01-24T14:02:52","slug":"elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/","title":{"rendered":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials"},"content":{"rendered":"<div>\n<p>AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/clinicalresearch?src=hash\" target=\"_blank\" rel=\"noopener\">#clinicalresearch<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elligohealthresearch.com%2F&amp;esheet=53289526&amp;newsitemid=20230124005277&amp;lan=en-US&amp;anchor=Elligo+Health+Research%26%23174%3B&amp;index=1&amp;md5=c5a110ccf90288ed7cddae792b278bbe\" rel=\"nofollow noopener\" shape=\"rect\">Elligo Health Research<sup>\u00ae<\/sup><\/a>, the largest healthcare-enabling research organization, has introduced Data<sup>AI <\/sup>Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, Data<sup>AI <\/sup>Connect creates efficiencies across the clinical study workflow \u2014 reducing human error and rapidly digesting patient data to accelerate clinical trials.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/5\/Elligo_Logo_Screen.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg\"><\/a><\/p>\n<p>\n\u201cThe application of AI approaches to healthcare and clinical study data is moving from the moon-shot approach to more practical applications,\u201d said Elligo\u2019s Chief Data Officer, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elligohealthresearch.com%2Fmeet-the-team%2Fmichael-ibara-pharm-d%2F&amp;esheet=53289526&amp;newsitemid=20230124005277&amp;lan=en-US&amp;anchor=Michael+Ibara&amp;index=2&amp;md5=11a58761a48ed67e77afcada884d51d3\" rel=\"nofollow noopener\" shape=\"rect\">Michael Ibara<\/a>, Pharm.D. \u201cAn example of this approach is the process of getting patients\u2019 medical records, which involves manual, non-scalable activities such as getting accurate information on patients\u2019 providers, asking sites to track down records, and having humans triage hundreds of pages of medical records. The judicious and intelligent application of natural language processing (NLP), machine learning (ML), and other AI approaches increases speed, accuracy and quality, while removing the burden from the sites and patients.\u201d\n<\/p>\n<p>\nBy bringing together data, processes, and clinical expertise, Elligo has created an industry first AI-driven platform that sources, processes, analyzes, and distributes patient real-world data (RWD) \u2014 meaning an end-to-end solution that solves the clinical trial challenges directly rather than being an add-on technology. The customizable, reusable platform includes:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nA RWD repository of electronic health records (EHRs) and clinical data storage that integrates EHR, clinical trial, and patient data for analytics, AI, and research.\n<\/li>\n<li>\nA complete medical records retrieval and analytics solution that transforms data in minutes into searchable, actionable insights and individual patient journey information through proper use of NLP, ML, and clinical expertise.\n<\/li>\n<li>\nA data-driven protocol development service that tests designs in the real world.\n<\/li>\n<\/ul>\n<p>\nFor more information about how AI-driven technology is optimizing clinical data management and accelerating clinical trials through healthcare, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elligohealthresearch.com%2Ffor-sponsors%2F&amp;esheet=53289526&amp;newsitemid=20230124005277&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.elligohealthresearch.com%2Ffor-sponsors%2F&amp;index=3&amp;md5=dbf1e0c08333735a8fec6f4ac7774836\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.elligohealthresearch.com\/for-sponsors\/<\/a>.\n<\/p>\n<p>\n<strong>About Elligo Health Research<\/strong><b><sup>\u00ae<\/sup><\/b>\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elligohealthresearch.com%2F&amp;esheet=53289526&amp;newsitemid=20230124005277&amp;lan=en-US&amp;anchor=Elligo+Health+Research&amp;index=4&amp;md5=4356161d438d3a461d70ad0edfe42a0d\" rel=\"nofollow noopener\" shape=\"rect\">Elligo Health Research<\/a> accelerates clinical trials through healthcare with access to over 150 million known patients and their HIPAA-compliant healthcare data, our IntElligo<sup>\u00ae<\/sup> Research Stack technology, and our Patient<i>Select<\/i> identification and engagement model. Coupled with the largest Known Patient Access Network, Elligo\u2019s Site Solutions enable healthcare practices and research sites to participate in clinical trials. By adaptive engagement of known patients and physicians, we accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nLindsey Langemeier<br \/>\n<br \/>SCORR Marketing<br \/>\n<br \/>402-405-4269<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6c;&#105;&#x6e;&#100;&#x73;e&#x79;&#64;&#x73;c&#x6f;r&#x72;m&#x61;r&#107;&#x65;&#116;&#x69;&#110;&#x67;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#108;&#x69;&#110;&#x64;s&#x65;y&#64;&#x73;&#99;&#x6f;&#114;&#x72;m&#x61;r&#107;&#x65;&#116;&#x69;n&#x67;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;#clinicalresearch&#8212;Elligo Health Research\u00ae, the largest healthcare-enabling research organization, has introduced DataAI Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, DataAI Connect creates efficiencies across the clinical study workflow \u2014 reducing human error and rapidly digesting patient data to accelerate clinical trials. \u201cThe &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53230","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;#clinicalresearch&#8212;Elligo Health Research\u00ae, the largest healthcare-enabling research organization, has introduced DataAI Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, DataAI Connect creates efficiencies across the clinical study workflow \u2014 reducing human error and rapidly digesting patient data to accelerate clinical trials. \u201cThe ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-24T14:02:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials\",\"datePublished\":\"2023-01-24T14:02:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/\"},\"wordCount\":401,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005277\\\/en\\\/1693512\\\/21\\\/Elligo_Logo_Screen.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/\",\"name\":\"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005277\\\/en\\\/1693512\\\/21\\\/Elligo_Logo_Screen.jpg\",\"datePublished\":\"2023-01-24T14:02:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005277\\\/en\\\/1693512\\\/21\\\/Elligo_Logo_Screen.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005277\\\/en\\\/1693512\\\/21\\\/Elligo_Logo_Screen.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/","og_locale":"en_US","og_type":"article","og_title":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend","og_description":"AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;#clinicalresearch&#8212;Elligo Health Research\u00ae, the largest healthcare-enabling research organization, has introduced DataAI Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, DataAI Connect creates efficiencies across the clinical study workflow \u2014 reducing human error and rapidly digesting patient data to accelerate clinical trials. \u201cThe ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-24T14:02:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials","datePublished":"2023-01-24T14:02:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/"},"wordCount":401,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/","url":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/","name":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg","datePublished":"2023-01-24T14:02:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230124005277\/en\/1693512\/21\/Elligo_Logo_Screen.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/elligo-adds-ai-driven-clinical-research-study-technology-to-accelerate-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53230"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53230\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}